The lead researcher on the study of molecular radiotherapy at the University College Hospital has said that it may offer new treatment for some children.
UK doctors have launched a new trial which offers a new type of molecular radiotherapy - never before tested in children - for one of the deadliest childhood cancers. The new treatment uses radiotherapy which piggy-backs on a drug that naturally attaches itself to neuroblastoma cells.
Neuroblastoma is usually diagnosed in children aged five and under, and the aggressive form of the disease remains very difficult to treat successfully. Around 24 patients between 18 months and 18 years old will be treated in the LuDO neuroblastoma trial, at University College Hospital, London.
The treatment will be delivered directly to the tumour in up to four courses once every eight weeks. This treatment is effective in adults with other cancer types, but this is the first time it has been tried in children with neuroblastoma.